Table 1.
Patient | 1.1 | 1.2 | 2.1 | 3.1 | 3.2 | 3.3 |
---|---|---|---|---|---|---|
Consanguinity (parental relatedness) | No | No | No | Yes | Yes | Yes |
Gender | Female | Male | Male | Male | Female | Female |
Age at examination | 15 y | 13 y | 17 y | 17 y | 14 y | 10 y |
Intellectual disability | Moderate | Moderate | Moderate | Severe to profound | Severe to profound | Severe to profound |
Weight at birth | 54th percentile | 59th percentile | 2nd percentile | NA | NA | NA |
Head circumference at examination | 1st percentile | 1st percentile | <1st percentile | <1st percentile | <1st percentile | <1st percentile |
Height at examination | NA; <5th percentile throughout childhood | NA; <1st percentile based on most recent clinical note | 21st percentile | 1st percentile | <1st percentile | <1st percentile |
Weight at examination | NA; <5th percentile throughout childhood | NA; <1st percentile based on most recent clinical note | 10th percentile | 8th percentile | 1st percentile | 2nd percentile |
Motor development | Delayed motor signs by 17 mo; apraxia | Delayed motor signs by 9–12 mo; head holding at 2–3 mo; standing at 14 mo | Normal gross motor development | Delayed motor development | Delayed motor development | Delayed motor development |
Age of being able to walk | 4 y | 2 y | 13–14 mo | 3 y | 4 y | 6 y |
Subsequent deterioration in walking | No | No | No | Yes, after fall at 4 y | No | No |
Speech | Dysarthria; globally impaired | Dysarthria; speech apraxia; globally delayed | Delayed | Non-verbal; communicates with gestures | Monotone speech; some dysarthria | Monotone speech; some dysarthria |
Oral-motor function | Drooling; vomiting | Drooling; vomiting | Normal | Severe impairment in oral-motor skills; drooling | Severe impairment in oral-motor skills; drooling | Severe impairment in oral-motor skills; drooling |
Motor examination | Spasticity; increased tone in legs in terms of rotation; hyperreflexia; bilateral coordination impaired; wide-based gait; mild scissoring | Spasticity; increased tone in legs in terms of rotation; hyperreflexia in all joints, with 4–5 beats of clonus bilaterally in ankles | Strength and tone normal; abnormal gait | Hyperreflexia at all joints; severely impaired coordination | Strength reduced (power 3/5); tone normal; no spasticity of upper or lower limbs; hyperreflexia at all joints; poor motor coordination | Strength reduced (power 4/5); tone normal; no spasticity of upper or lower limb; hyperreflexia at all joints; severely impaired coordination |
Data supporting seizures/epilepsy | 1st seizure at 9 y; EEG in 2012 showed bursts of generalized 3-Hz spike and wave activity | 1st seizure around 9 y; medically refractory epilepsy; currently prescribed lamotrigine and cannabidiol oil | No seizures observed | Equivocal falling behavior, but seizure workup unavailable | No seizures observed | Equivocal falling behavior, but seizure workup unavailable |
Imaging | CT/MRI-MR spectroscopy in 2008 normal | MRI showed bilateral prominent perivascular spaces at centrum semiovale | CT of head normal | Low resolution MRI normal | Low resolution MRI normal | Low resolution MRI normal |
GPT2 mutationa | Compound heterozygous c.812A>C (p.N271T)/c.1432_1433delGT (p.V478Rfs*73) | Compound heterozygous c.812A>C (p.N271T)/c.1432_1433delGT (p.V478Rfs*73) | Homozygous c.775T>C (p.C259R) | Homozygous c.1210C>T (p.R404*) | Homozygous c.1210C>T (p.R404*) | Homozygous c.1210C>T (p.R404*) |
Positions of mutations are according to transcript NM_133443.3.
y years, mo months, NA not available